Anjali Singh

ASG Eye Hospital to invest ₹2,000 crore, scale to 600-700 centres

ASG Eye Hospital will invest Rs 2,000 crore to expand from 175-plus centres to 600-700 by 2030, using acquisitions, new hospitals and district centres, backed by investors

NephroPlus plans global scale-up ahead of IPO amid rising CKD burden

India's largest dialysis provider plans to expand clinics at home and abroad ahead of its December 10 IPO, betting on rising CKD burden and demand for accessible dialysis care

Corona Remedies bets on female hormone complex generics ahead of IPO

Corona Remedies is pushing into female hormone complex generics to expand beyond India, as its Rs 655.3-crore OFS IPO opens December 8, with a new hormone plant and a stake in La Chandra Pharma Labs

Claims vs reality: Dust doesn't settle on Mumbai's clean-air drive

- On paper, machines are deployed daily but residents, workers and vendors say dust still hangs heavy in the air

Mumbai gasps under a blanket of smog, BMC swings into pollution-war mode

The civic body said Mumbai's air quality has improved since November 26, supported by ongoing measures and wind speeds rising to 10-18 kilometres per hour

Lupin gets US FDA nod for its first biosimilar drug Pegfilgrastim

The product, a biosimilar to Amgen's popular drug Neulasta, will be manufactured at Lupin's biotech facility in Pune

M&M to build high-power highway network as it expands EV portfolio

Mahindra plans to deploy 1,000 ultra-fast highway chargers by 2027 across 250 major corridors, complementing its growing INGLO-based electric SUV lineup and rising EV production capacity

Cipla launches India's first integrated lung diagnostics, wellness centre

The Delhi facility offers over 60 advanced tests and aims to close critical gaps in respiratory diagnosis and care

Two-wheeler sales soar to record high in Oct on GST cuts, festive demand

India's two-wheeler industry recorded its best-ever monthly sales in October 2025, buoyed by GST 2.0 rate cuts, festive buying and strong rural demand, with ICRA projecting steady growth for FY26.

Tata Motors targets 20-25% SUV share with new Sierra: MD & CEO Chandra

Eyes doubling EV volumes in FY26

Zypp Electric targets 5x fleet in 2-3 years: Cofounder and CEO Akash Gupta

The company aims to enter 25 cities and capture 10-12 per cent of all last-mile deliveries in these markets

Apollo Hospitals opens new 400-bed quaternary care facility in Pune

Apollo Hospitals has inaugurated its newest quaternary care centre in Pune, expanding its western India network with advanced specialties, digital systems, and high-acuity services

Skoda Auto Volkswagen India crosses 2 million local production milestone

SAVWIPL has crossed two million locally built vehicles, powered by strong sales, an India-focused platform strategy and rising exports across global markets

India's metabolic crisis deepens as young adults face diabetes surge

Diabetes is increasingly becoming a major global health concern, with an estimated 589 million adults currently living with the condition and the number expected to rise to 853 million by 2050

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

80% of Indians with disabilities lack health insurance, warns NCPEDP

A new NCPEDP white paper reveals that most persons with disabilities in India remain uninsured, face high rejection rates and encounter discriminatory practices across public and private schemes

JSW MG Windsor EV crosses 50,000 sales in under 400 days of launch

MG's Windsor EV has crossed 50,000 sales in just over 13 months, becoming India's fastest four-wheeler EV to reach the milestone and sharply lifting the company's electric vehicle market share

India's three-wheeler makers likely to clock nearly 7% growth in FY26

Mkt likely to continue growth momentum in H2FY26, backed by Oct sales

Lilly's Donanemab gets CDSCO approval for early Alzheimer's treatment

Eli Lilly has secured CDSCO marketing authorisation for donanemab, an amyloid-targeting therapy for adults with early symptomatic Alzheimer's

AstraZeneca, Sun Pharma sign deal to distribute hyperkalaemia drug in India

AstraZeneca Pharma India and Sun Pharmaceutical Industries have formed an exclusive brand partnership to promote and distribute SZC for hyperkalaemia treatment under separate brands